SCHEMBL5492437

SCHEMBL5492437

C=Cc1ccc(N(c2ccc(OC)c(C)c2)c2ccc(OC)c(C)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.44
NQO2 P16083 1/20 0.41
TSHR P16473 3/20 0.38
MAPK1 P28482 2/20 0.38
TUBB1 Q9H4B7 7/20 0.36
TUBB4A P04350 2/20 0.36
TUBB P07437 2/20 0.36
TUBA3C P0DPH7 2/20 0.36
TUBA1B P68363 2/20 0.36
TUBA4A P68366 2/20 0.36
TUBB4B P68371 2/20 0.36
TUBB3 Q13509 2/20 0.36
TUBB2A Q13885 2/20 0.36
TUBB8 Q3ZCM7 2/20 0.36
TUBA3E Q6PEY2 2/20 0.36
TUBA1A Q71U36 2/20 0.36
TUBA1C Q9BQE3 2/20 0.36
TUBB6 Q9BUF5 2/20 0.36
TUBB2B Q9BVA1 2/20 0.36
ALDH1A1 P00352 5/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5487252 0.84 NQO2 (0.55) NQO2TUBB1TUBB4ATUBBTUBA3C
SCHEMBL2602461 0.81 ALDH1A1 (0.42) TRPA1TSHRTUBB1ALDH1A1MAPT
SCHEMBL2602495 0.81 ALDH1A1 (0.42) TRPA1TSHRTUBB1ALDH1A1MAPT
SCHEMBL30119825 0.81 TRPA1 (0.58) TRPA1TSHRMAPK1TUBB1TUBB4A
SCHEMBL165188 0.81 TRPA1 (0.58) TRPA1TSHRMAPK1TUBB1TUBB4A
SCHEMBL10047112 0.79 NQO2 (0.67) NQO2TUBB1TUBB4ATUBBTUBA3C
SCHEMBL5289507 0.75 ALDH1A1 (0.47) TRPA1NQO2TSHRTUBB1TUBB4A
SCHEMBL11987113 0.75 ALDH1A1 (0.47) TRPA1NQO2TSHRTUBB1TUBB4A
SCHEMBL8943672 0.74 SLC16A3 (0.44) TSHRALDH1A1KDM4EMAPTKMT2A
SCHEMBL2602569 0.74 ALDH1A1 (0.35) ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276627-B2 One pot sequential reactions and novel products produced thereby IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2007-10-02 US claimed
US-20060224017-A1 One pot sequential reactions and novel products produced thereby IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2006-10-05 US claimed
US-7276627-B2 One pot sequential reactions and novel products produced thereby IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2007-10-02 US disclosed
US-20060224017-A1 One pot sequential reactions and novel products produced thereby IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060224017-A1 One pot sequential reactions and novel products produced thereby PNMT, CYP1A1, TERT TRPA1 1677/4885NQO2 164/4885TSHR 3843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.